Inventor profile of:

Thomas HOFER

City:

Schlieren

Country:

Switzerland

Published Applications:

17

Last publication date:

2026-05-07

Top Assignees for applications by Thomas HOFER

The entities that hold a legal rights for patent applications filed by inventor HOFER Thomas:

Recent patent applications by HOFER Thomas

Thomas HOFER from Schlieren, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-07
US20260125469A1
Chemistry; metallurgy

ANTIBODIES BINDING TO CD3

#2 | 2025-02-20
US20250059298A1
Chemistry; metallurgy

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2

#3 | 2024-02-08
US20240042022A1
Human necessities

ANTIBODIES BINDING TO CD3

#4 | 2023-12-28
US20230416365A1
Chemistry; metallurgy

TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES

#5 | 2023-09-07
US20230277662A1
Human necessities

ANTIBODIES BINDING TO CD3

#6 | 2022-01-20
US20220017637A1
Chemistry; metallurgy

Agonistic CD28 antigen binding molecules targeting Her2

#7 | 2022-01-13
US20220010015A1
Chemistry; metallurgy

ANTIBODIES BINDING TO CD3

#8 | 2021-12-30
US20210403562A1
Chemistry; metallurgy

Bispecific antibody molecules binding to CD3 and EGFRvIII

#9 | 2021-02-25
US20210054021A1
Chemistry; metallurgy

Stabilized immunoglobulin domains

#10 | 2020-11-12
US20200354457A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES COMPRISING AN ANTIGEN-BINDING SITE BINDING TO LAG3

#11 | 2020-10-08
US20200317774A1
Chemistry; metallurgy

ANTI-HUMAN CD19 ANTIBODIES WITH HIGH AFFINITY

#12 | 2020-08-27
US20200270347A1
Chemistry; metallurgy

Bispecific antibody molecules binding to CD3 and TYRP-1

#13 | 2020-07-16
US20200223925A1
Chemistry; metallurgy

TUMOR-TARGETED SUPERAGONISTIC CD28 ANTIGEN BINDING MOLECULES

#14 | 2020-06-25
US20200199234A1
Chemistry; metallurgy

Tumor-targeted agonistic CD28 antigen binding molecules

#15 | 2020-06-18
US20200190212A1
Chemistry; metallurgy

Antibodies binding to STEAP-1

#16 | 2018-08-16
US20180230215A1
Chemistry; metallurgy

ANTI-HUMAN CD19 ANTIBODIES WITH HIGH AFFINITY

#17 | 2017-04-06
US20170096495A1
Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

InventorID:

1842689 ⎘